215 related articles for article (PubMed ID: 19490068)
1. Adiponectin downregulates CD163 whose cellular and soluble forms are elevated in obesity.
Sporrer D; Weber M; Wanninger J; Weigert J; Neumeier M; Stögbauer F; Lieberer E; Bala M; Kopp A; Schäffler A; Buechler C
Eur J Clin Invest; 2009 Aug; 39(8):671-9. PubMed ID: 19490068
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin downregulates galectin-3 whose cellular form is elevated whereas its soluble form is reduced in type 2 diabetic monocytes.
Weber M; Sporrer D; Weigert J; Wanninger J; Neumeier M; Wurm S; Stögbauer F; Kopp A; Bala M; Schäffler A; Buechler C
FEBS Lett; 2009 Nov; 583(22):3718-24. PubMed ID: 19818774
[TBL] [Abstract][Full Text] [Related]
3. The macrophage-specific serum marker, soluble CD163, is increased in obesity and reduced after dietary-induced weight loss.
Fjeldborg K; Christiansen T; Bennetzen M; J Møller H; Pedersen SB; Richelsen B
Obesity (Silver Spring); 2013 Dec; 21(12):2437-43. PubMed ID: 23512476
[TBL] [Abstract][Full Text] [Related]
4. Soluble CD163 is not increased in visceral fat and steatotic liver and is even suppressed by free fatty acids in vitro.
Bauer S; Weiss TS; Wiest R; Schacherer D; Hellerbrand C; Farkas S; Scherer MN; Ritter M; Schmitz G; Schäffler A; Buechler C
Exp Mol Pathol; 2011 Dec; 91(3):733-9. PubMed ID: 21839737
[TBL] [Abstract][Full Text] [Related]
5. Expression of soluble sCD163 in serum of psoriatic patients is modulated by Goeckerman therapy.
Kondelkova K; Krejsek J; Borska L; Fiala Z; Hamakova K; Andrys C
Allergol Immunopathol (Madr); 2013; 41(3):158-62. PubMed ID: 22765877
[TBL] [Abstract][Full Text] [Related]
6. Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels.
Davis BH; Zarev PV
Cytometry B Clin Cytom; 2005 Jan; 63(1):16-22. PubMed ID: 15624200
[TBL] [Abstract][Full Text] [Related]
7. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
[TBL] [Abstract][Full Text] [Related]
8. Adiponectin upregulates monocytic activin A but systemic levels are not altered in obesity or type 2 diabetes.
Weigert J; Neumeier M; Wanninger J; Schober F; Sporrer D; Weber M; Schramm A; Wurm S; Stögbauer F; Filarsky M; Schäffler A; Aslanidis C; Schölmerich J; Buechler C
Cytokine; 2009 Feb; 45(2):86-91. PubMed ID: 19128983
[TBL] [Abstract][Full Text] [Related]
9. Soluble CD163 is associated with body mass index and blood pressure in hypertensive obese Saudi patients.
Al-Daghri NM; Al-Attas OS; Bindahman LS; Alokail MS; Alkharfy KM; Draz HM; Yakout S; McTernan PG; Sabico S; Chrousos GP
Eur J Clin Invest; 2012 Nov; 42(11):1221-6. PubMed ID: 22946776
[TBL] [Abstract][Full Text] [Related]
10. Soluble macrophage-derived CD163: a homogenous ectodomain protein with a dissociable haptoglobin-hemoglobin binding.
Møller HJ; Nielsen MJ; Maniecki MB; Madsen M; Moestrup SK
Immunobiology; 2010 May; 215(5):406-12. PubMed ID: 19581020
[TBL] [Abstract][Full Text] [Related]
11. Soluble CD163, a specific macrophage activation marker, is decreased by anti-TNF-α antibody treatment in active inflammatory bowel disease.
Dige A; Støy S; Thomsen KL; Hvas CL; Agnholt J; Dahlerup JF; Møller HJ; Grønbaek H
Scand J Immunol; 2014 Dec; 80(6):417-23. PubMed ID: 25346048
[TBL] [Abstract][Full Text] [Related]
12. Soluble CD163 is associated with CD163 mRNA expression in adipose tissue and with insulin sensitivity in steady-state condition but not in response to calorie restriction.
Kračmerová J; Rossmeislová L; Kováčová Z; Klimčáková E; Polák J; Tencerová M; Mališová L; Štich V; Langin D; Šiklová M
J Clin Endocrinol Metab; 2014 Mar; 99(3):E528-35. PubMed ID: 24423341
[TBL] [Abstract][Full Text] [Related]
13. Monocyte CD163 is altered in association with diabetic complications: possible protective role.
Min D; Brooks B; Wong J; Aamidor S; Seehoo R; Sutanto S; Harrisberg B; Yue DK; Twigg SM; McLennan SV
J Leukoc Biol; 2016 Dec; 100(6):1375-1383. PubMed ID: 27354410
[TBL] [Abstract][Full Text] [Related]
14. Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.
Baeten D; Møller HJ; Delanghe J; Veys EM; Moestrup SK; De Keyser F
Arthritis Rheum; 2004 May; 50(5):1611-23. PubMed ID: 15146432
[TBL] [Abstract][Full Text] [Related]
15. Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure.
Hiraoka A; Horiike N; Akbar SM; Michitaka K; Matsuyama T; Onji M
J Gastroenterol; 2005 Jan; 40(1):52-6. PubMed ID: 15692789
[TBL] [Abstract][Full Text] [Related]
16. Monocyte/macrophage-derived soluble CD163: a novel biomarker in multiple myeloma.
Andersen MN; Abildgaard N; Maniecki MB; Møller HJ; Andersen NF
Eur J Haematol; 2014 Jul; 93(1):41-7. PubMed ID: 24612259
[TBL] [Abstract][Full Text] [Related]
17. Changes in fat mass correlate with changes in soluble sCD163, a marker of mature macrophages, in patients with CKD.
Axelsson J; Møller HJ; Witasp A; Qureshi AR; Carrero JJ; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Moestrup SK; Stenvinkel P
Am J Kidney Dis; 2006 Dec; 48(6):916-25. PubMed ID: 17162146
[TBL] [Abstract][Full Text] [Related]
18. CD163 expression is increased in the involved skin and sera of patients with systemic lupus erythematosus.
Nakayama W; Jinnin M; Makino K; Kajihara I; Makino T; Fukushima S; Sakai K; Inoue Y; Ihn H
Eur J Dermatol; 2012; 22(4):512-7. PubMed ID: 22576016
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight adiponectin negatively correlates with the waist circumference and monocytic IL-6 release.
Schober F; Neumeier M; Weigert J; Wurm S; Wanninger J; Schäffler A; Dada A; Liebisch G; Schmitz G; Aslanidis C; Buechler C
Biochem Biophys Res Commun; 2007 Oct; 361(4):968-73. PubMed ID: 17678873
[TBL] [Abstract][Full Text] [Related]
20. Soluble CD163 and interleukin-6 are increased in aqueous humour from patients with endothelial rejection of corneal grafts.
Funding M; Vorum H; Nexø E; Moestrup SK; Ehlers N; Møller HJ
Acta Ophthalmol Scand; 2005 Apr; 83(2):234-9. PubMed ID: 15799739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
